Commerzbank set a €62.00 ($73.81) target price on Compugroup Medical (ETR:COP) in a report released on Thursday morning. The firm currently has a buy rating on the stock.

Several other analysts have also recently commented on the stock. Baader Bank set a €52.00 ($61.90) price objective on shares of Compugroup Medical and gave the company a neutral rating in a research note on Wednesday. Deutsche Bank set a €65.00 ($77.38) price objective on shares of Compugroup Medical and gave the company a buy rating in a research note on Tuesday, November 14th. Warburg Research set a €56.00 ($66.67) price objective on shares of Compugroup Medical and gave the company a buy rating in a research note on Friday, November 10th. Berenberg Bank set a €53.00 ($63.10) price objective on shares of Compugroup Medical and gave the company a neutral rating in a research note on Friday, November 10th. Finally, set a €61.00 ($72.62) price objective on shares of Compugroup Medical and gave the company a buy rating in a research note on Wednesday, October 18th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Compugroup Medical currently has an average rating of Buy and a consensus target price of €58.17 ($69.25).

Shares of Compugroup Medical (COP) opened at €55.72 ($66.33) on Thursday. Compugroup Medical has a 52 week low of €36.12 ($43.00) and a 52 week high of €57.70 ($68.69).

TRADEMARK VIOLATION NOTICE: “Commerzbank Analysts Give Compugroup Medical (COP) a €62.00 Price Target” was reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark laws. The original version of this news story can be accessed at https://theolympiareport.com/2017/12/17/commerzbank-analysts-give-compugroup-medical-cop-a-62-00-price-target.html.

Compugroup Medical Company Profile

CompuGroup Medical Societas Europaea develops and sells software, as well as information technology services for healthcare sector worldwide. It operates through three segments: Health Provider Services I, Health Provider Services II, and Health Connectivity Services. The company is involved in the development and sale of practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physicianÂ’s networks; and integral clinical, administrative, and financial software applications for pharmacies and mail order pharmacies.

Analyst Recommendations for Compugroup Medical (ETR:COP)

Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with Analyst Ratings Network's FREE daily email newsletter.